The validation of this concept will have to await the availability of surgical brain tumor samples obtained from patients undergoing this treatment, which can be subjected to immunohistochemistry for typical pro-apoptotic ER stress markers, such as CHOP (also called GADD153) [137]. The gene discussed is DDIT3; the disease is brain neoplasm.